|Articles|March 7, 2012

Conducting Clinical Trials in China

Author(s)Kayda Norman

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

What It Actually Means to Embed the Patient Voice in Trial Design

ByAmélie Lothe,Andy Studna, Senior Editor

September 10th 2026

ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization

ByAndy Studna, Senior Editor

September 10th 2026

© putilov_denis - © putilov_denis - stock.adobe.com

From Participation to Understanding: Reframing Engagement in Clinical Trials

September 9th 2026

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable

ByOtis Johnson, PhD, MPA,Joseph Geraci, PhD,Andy Studna, Senior Editor

September 9th 2026

ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis

ByAndy Studna, Senior Editor

September 9th 2026

Trending on Applied Clinical Trials Online

From Participation to Understanding: Reframing Engagement in Clinical Trials

Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization

ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis